Glivec in Ph Positive Lymphoblastic Leukemia

Clinical trial NCT00388895 · COMPLETED

Trial details

NCT number: NCT00388895
Sponsor: PETHEMA Foundation
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Lymphoblastic Leukemia Cromosome Philadelphia Positive

Start date: 2002-06-01
Primary completion: 2006-10-01
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.